First-Line Immunotherapy for Non-Small-Cell Lung Cancer. Reck M, Remon J, Hellmann MD. J Clin Oncol 2022 Jan 5:JCO2101497. doi: 10.1200/JCO.21.01497.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reck M, Remon J, Hellmann MD. First-Line Immunotherapy for Non-Small-Cell Lung Cancer. J Clin Oncol 2022 Jan 5:JCO2101497. doi: 10.1200/JCO.21.01497.
PMID: 34985920